President & Owner

Meet J. Edward Nolan, MD

Dr. Nolan began his private practice in 2002, opening Trident Pain Center in North Charleston. Under his direction, the practice has grown remarkably to include multiple locations.

About Dr. Edward Nolan

Joseph Edward (“Ed”) Nolan has been practicing medicine since 1996. He received his Doctor of Medicine Degree from the Medical University of South Carolina. Dr. Nolan served his General Surgery Internship at MUSC, and completed his Anesthesiology Residency and Pain Fellowship there as well. He is Board Certified in Pain Management and specializes in interventional pain management for neck and back pain 

Dr. Nolan began his private practice in 2002, opening Trident Pain Center in North Charleston. Under his direction, the practice has grown remarkably to include multiple locations. Each day Dr. Nolan strives to provide exceptional patient care; his dedication and compassion are evident in the standards of excellence he has established within his practice. 

Dr. Nolan first opened Hyper Healing Medical Clinics in Florida in the summer of 2016. Under his leadership, he has expanded into both Florida and South Carolina creating multiple locations.

In Dr. Nolan’s time away from the practice, he can be found enjoying the outdoors or spending time with his family.

 

CURRICULUM VITAE

 

Title: Medical Director / Principal Investigator / Owner

Medical License:  State of South Carolina License # 19839

 

BUSINESS

Hyper Healing Medical Clinics, LLC
4915 Ehrlich Rd, 
Tampa, FL 33624
(813) 591-4570
 

Trident Pain Center, LLC
9267 Medical Plaza Drive, Suite G
North Charleston, SC 29406
Phone (843) 797-3636 / Fax (843) 797-3637
Medical Director / Owner (September 2002-Present)

 

Trident Institute of Medical Research, LLC
9267 Medical Plaza Drive, Suite G
North Charleston, SC 29406
Phone (843) 266-6090 / Fax (843) 266-6099
Principal Investigator / Owner (April 2007-October 2014)

 

EDUCATION & TRAINING

  • Degree: Bachelor of Arts in Chemistry, Minor in Accounting and Business Administration
    Southern College, Collegedale, TN (1981-1986)
    Graduated Cum Laude
  • Degree: Doctor of Medicine
    Medical University of South Carolina, Charleston, SC (1992-1996)
  • General Surgery Internship
    Department of Surgery
    Medical University of South Carolina, Charleston, SC (1996-1997)
  • Resident in Anesthesiology
    Department of Anesthesiology and Perioperative Medicine
    Medical University of South Carolina, Charleston, SC (1997-2000)
  • Pain Fellowship
    Department of Anesthesiology and Perioperative Medicine
    Medical University of South Carolina, Charleston, SC (2000-2001)
    Good Clinical Practice for Clinical Research Professionals – ACRP (2007)
  • Appointment
    Clinical Assistant Professor
    Department of Anesthesiology
    Medical University of South Carolina
    165 Ashley Avenue, Suite 525
    Post Office Box 250912
    Charleston, SC 29425
    Phone (843) 792-2322

CERTIFICATES & MEMBERSHIP

  • Diplomate, American Board of Anesthesiology (2001)
  • Additional qualifications in Pain Management (2003)
  • Diplomate, National Board of Medical Examiners (1997)
  • South Carolina State Board of Medical Examiners (1997)
  • American Medical Association
  • SC Medical Association
  • American Society of Interventional Pain Physicians
  • Association of Clinical Research Professionals (2007)

PUBLICATIONS

  • Evaluation of Residency Provided Home Computers in Anesthesia Education, Computer Literacy, and Interdepartmental Communication: Results of a Resident Survey. American Journal of Anesthesiology (1999)

PRESENTATIONS

  • Numerous local presentations discussing “Advances in Pain Management”
  • “Computer Education in Anesthesia Residency”
    Presented Annual Meeting – American Society of Anesthesiologists, (1998)
  • “Musculoskeletal Infections in Transplant Patients”
    Third Place – SC Orthopedic Association Annual Meeting (1997)

RESEARCH

  • “A Multicenter, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Lubiprostone in Patients with Opioid-induced Bowel Dysfunction” (2007-2009)
  • “A Six Week Double-Blind, Randomized, Multicenter Comparison Study of the Analgesic Effectiveness of Celecoxib 200 mg BID Compared to Tramadol Hydrochloride 50 mg QID in Subjects with Chronic Low Back Pain” (2008-July 18, 2008)
  • “A Phase III, Variable-Dose Titration Followed by a Randomized Double-Blind Study of Controlled-Release OROS® Hydromorphone HCl (NMED-1077) Compared to Placebo in Patients with Chronic Low Back Pain” (2008-January 2009)
  • “A Randomized, Double Blind, Active Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Compared With Immediate Release Oxycodone for the Management of Breakthrough Pain in Opioid Tolerant Patients With Chronic Pain, Followed by a 12 Week Open Label Extension to Evaluate the Impact of Fentanyl Buccal Tablets on Patient Outcomes” (2008-2010)
  • “Opioid Utilization Study (OPUS) in Chronic non-cancer pain” (2008-2010)
  • “A Prospective, Multi-Center, Observational Registry of Patients Using Prescription Medications Containing Oxycodone Immediate Release for the Treatment of Pain” (June 2009-2010)
  • “A Multi-center, Primary Care-Based, Open-Label Study to Assess the Success of Converting Opioid Experienced Patients With Chronic, Moderate to Severe
    Pain, to EMBEDA™ Using a Standardized Conversion Guide, and to Identify Behaviors Related to Prescription Opioid Abuse, Misuse and Diversion” (Study was discontinued by Pfizer)
  • “A 12-Month, Open-Label Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 15 to 90 mg Every 12 Hours in Patients Who Require Opioid Treatment for an Extended Period of Time”
  • “A 12-Week Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets
    (CEP-33237) at 15 to 90 mg Every 12 Hours for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time”
  • “A Randomized, Double Blind, Placebo-Controlled, Ascending-Dose Study to Evaluate the Safety and Efficacy of CEP-37247 Administered at Single Doses of 0.5, 1, 3, 6 or 12mg by the Transforaminal Epidural Route for the Treatment of Patient With Lumbosacral Radicular Pain Associated With Disc Herniation”

EDUCATIONAL SPEAKER

  • Cephalon, Inc (2010 to present)
  • Mallinckrodt, Inc (2011 to present)
  • Covidien, Inc (2012 to present)

 

We are ready to help!

At Hyper Healing we are the experts in advanced wound healing. If you or a loved one is suffering from chronic non-healing wounds, click the button below to request an appointment at a location near you.

Covered Conditions

Cash Pay

Covered Conditions

Cash Pay

Covered Conditions